ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Other Non-current Assets
Long-term assets not reported separately.
No reported Other Non-current Assets figures are available to summarize.
Other Non-current Assets history
Currency unavailable · from the balance sheet
No Other Non-current Assets data reported for this period type.
Other Non-current Assets vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $14.69M USD | +4.5% | -1.0% | 5.0% | |
| Mar 2026 | $3.68M USD | +18.1% | +34.5% | 1.5% | |
| Mar 2026 | $3.23M USD | +347.6% | +472.0% | 0.7% | |
| Mar 2026 | $2.03M USD | -89.0% | — | 0.8% | |
| Mar 2026 | $386K USD | -90.9% | -83.7% | 0.1% | |
| Mar 2026 | $127K USD | -96.5% | — | 0.1% | |
| Mar 2026 | $67K USD | -25.6% | -19.6% | 0.0% | |
| Mar 2026 | €0 EUR | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -25.6% | -1.0% | 0.1% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.